C12Y 306/00
Hydrolases acting on acid anhydrides
Official title: Hydrolases acting on acid anhydrides (3.6)
C12Y306/00 (Hydrolases acting on acid anhydrides) appears on 416 US grants and 823 published applications in this corpus.
Search patents in C12Y- Granted patents
- 416
- Published applications
- 823
- Assignees
- 489
- Inventors
- 1,819
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 3 |
| 2003 | 0 | 7 |
| 2004 | 8 | 4 |
| 2005 | 3 | 5 |
| 2006 | 1 | 9 |
| 2007 | 1 | 4 |
| 2008 | 1 | 11 |
| 2009 | 4 | 8 |
| 2010 | 3 | 11 |
| 2011 | 4 | 15 |
| 2012 | 5 | 13 |
| 2013 | 8 | 20 |
| 2014 | 14 | 22 |
| 2015 | 17 | 51 |
| 2016 | 21 | 40 |
| 2017 | 25 | 63 |
| 2018 | 28 | 43 |
| 2019 | 33 | 34 |
| 2020 | 36 | 60 |
| 2021 | 45 | 57 |
| 2022 | 32 | 57 |
| 2023 | 29 | 66 |
| 2024 | 35 | 70 |
| 2025 | 30 | 87 |
| 2026 | 25 | 63 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Genetically engineered phagocytes, and related compositions, vectors, methods and systems22 Sep 2026US 12,741,025 B2The Regents of the University of California
- Rat models for CMT2A that develop a progressive neuropathy1 Sep 2026US 12,721,327 B2Charcot-Marie-Tooth Association
- Methods and compositions for the expression of constitutively active RAP1A from a VMD2 promoter25 Aug 2026US 12,714,757 B2University of Flordia Research Foundation, Inc.
- Methods for inducing full ablation of hematopoiesis14 Jul 2026US 12,678,491 B2Assistance Publique-HôPitaux De Paris (Aphp)
- Combination treatment by administering a recombinant apyrase protein in conjunction with a P2Y12 inhibitor30 Jun 2026US 12,668,785 B2AstraZeneca AB
- Hypoxia-Resistant Immune Cells for Sustained Persistence and Functionality in the Hypoxic Tumor Microenvironment1 Oct 2026US 2026/0297527 A1Universiteit Antwerpen
- Modified helicases1 Oct 2026US 2026/0297544 A1Oxford Nanopore Technologies PLC
- Novel abc transporter permease variant and method for producing 5’-inosinic acid using same1 Oct 2026US 2026/0297640 A1Daesang Corporation
- Fusion proteins for improved gene editing24 Sep 2026US 2026/0286397 A1New York Genome Center, Inc.
- Nonsense mediated decay inhibitor compounds17 Sep 2026US 2026/0272923 A1The Johns Hopkins University
Most cited
By later US patents
- Combined use of .beta.-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides130US 5,374,541 ACytel Corporation · 1994
- Pancreatic cancer targets and uses thereof104US 7,473,531 B1Colora Corporation · 2009
- CFTR mRNA compositions and related methods and uses44US 9,181,321 B2ethris GmbH · 2015
- Method for screening inhibitors of Ras41US 9,810,690 B2Araxes Pharma LLC · 2017
- Enzyme stalling method36US 10,221,450 B2Oxford Nanopore Technologies PLC · 2019